Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,776,666
  • Shares Outstanding, K 111,242
  • Annual Sales, $ 9,872 M
  • Annual Income, $ 871,000 K
  • EBIT $ 1,685 M
  • EBITDA $ 2,178 M
  • 60-Month Beta 0.64
  • Price/Sales 1.96
  • Price/Cash Flow 13.33
  • Price/Book 2.74

Options Overview Details

View History
  • Implied Volatility 26.55% (-0.12%)
  • Historical Volatility 22.95%
  • IV Percentile 84%
  • IV Rank 42.36%
  • IV High 39.40% on 04/11/25
  • IV Low 17.11% on 08/15/25
  • Expected Move (DTE 1) 12.50 (6.57%)
  • Put/Call Vol Ratio 0.70
  • Today's Volume 273
  • Volume Avg (30-Day) 731
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 11,249
  • Open Int (30-Day) 9,931
  • Expected Range 177.76 to 202.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.36
  • Number of Estimates 9
  • High Estimate 2.43
  • Low Estimate 2.32
  • Prior Year 2.23
  • Growth Rate Est. (year over year) +5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
171.18 +11.15%
on 01/05/26
190.99 -0.38%
on 01/15/26
+6.15 (+3.34%)
since 12/15/25
3-Month
171.18 +11.15%
on 01/05/26
197.55 -3.69%
on 10/21/25
+2.91 (+1.55%)
since 10/15/25
52-Week
148.70 +27.95%
on 01/16/25
197.55 -3.69%
on 10/21/25
+39.93 (+26.56%)
since 01/15/25

Most Recent Stories

More News
Sonora Quest and Laboratory Sciences of Arizona Announce Jennifer Erickson as CEO-Elect

Jennifer Erickson succeeds   longtime CEO David Dexter following more than 26 years of service

DGX : 190.26 (+1.87%)
3 Mid-Cap Stocks We Find Risky

3 Mid-Cap Stocks We Find Risky

DGX : 190.26 (+1.87%)
BG : 108.83 (+3.20%)
BF.B : 27.42 (+0.81%)
3 Reasons to Sell DGX and 1 Stock to Buy Instead

3 Reasons to Sell DGX and 1 Stock to Buy Instead

DGX : 190.26 (+1.87%)
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026

Planned Leadership Transition Positions Company for Growth Company Expects to Exceed Revenue and Cash Guidance for the Full Year 2025

DGX : 190.26 (+1.87%)
EXAS : 102.34 (+0.08%)
ILMN : 145.30 (+0.92%)
ARVN : 12.13 (-0.57%)
PFE : 25.89 (+1.21%)
QTRX : 7.95 (+8.16%)
Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

SECAUCUS, N.J. , Jan. 8, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that it will report fourth quarter and full...

DGX : 190.26 (+1.87%)
Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium

SECAUCUS, N.J. , Jan. 6, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that data will be shared on circulating tumor...

DGX : 190.26 (+1.87%)
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan

Quest also now provides comprehensive Collaborative Lab Solutions (Co-Lab) hospital lab management services for all 21 Corewell Health hospitals  

DGX : 190.26 (+1.87%)
What You Need To Know Ahead of Quest Diagnostics' Earnings Release

Quest Diagnostics is expected to unveil its fourth-quarter results soon, and analysts expect a single-digit growth in earnings.

ABT : 123.53 (-1.18%)
XLV : 156.96 (-0.57%)
DGX : 190.26 (+1.87%)
$SPX : 6,944.47 (+0.26%)
Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

Q3 Earnings Highlights: Quest (NYSE:DGX) Vs The Rest Of The Testing & Diagnostics Services Stocks

DGX : 190.26 (+1.87%)
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks?

Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.

XLV : 156.96 (-0.57%)
HSIC : 78.08 (+2.39%)
DGX : 190.26 (+1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 196.58
2nd Resistance Point 193.79
1st Resistance Point 192.02
Last Price 190.26
1st Support Level 187.46
2nd Support Level 184.67
3rd Support Level 182.90

See More

52-Week High 197.55
Last Price 190.26
Fibonacci 61.8% 178.89
Fibonacci 50% 173.13
Fibonacci 38.2% 167.36
52-Week Low 148.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar